Launched in 2014, the Centre of Regulatory Excellence (CoRE) at Duke-NUS Medical School, is the first dedicated Asian centre targeted at the needs of national health regulators, the biomedical industry, and pharmaceutical and medical device companies. CoRE provides a platform to develop programmes that build leadership capability among senior staff and executives, promote regulatory leadership and encourage policy innovation across the Asia-Pacific.
Being part of the Duke-NUS Medical School in Singapore provides CoRE the unparalleled access to the region and a world of networks. Given the recent boom in the biomedical and life sciences fields in Asia, CoRE aims to support public and private bodies in their development of strong regulatory capabilities, and encourage innovation through thought leadership and best practices. Ultimately, CoRE’s aim is to create an environment in which new healthcare products can be developed, commercialised and delivered to populations across Asia with greater efficacy and safety.
Yet, a noticeable vacuum has arisen, making the healthcare environment increasingly complex and posing difficulties. A shortage of regulatory expertise, lack of support systems to facilitate regional regulatory policy innovations and diverse regulatory requirements across different countries are just a few issues which present themselves.
By listening to these unique issues prevalent in Asia, Singapore recognizes a need for the creation of a neutral platform to help regulatory growth take shape and create an environment in which regulatory policy can be developed to create measurable results through improved health outcomes; preventing deaths and illnesses and enhancing the quality of life
In 2014, Singapore launched the first dedicated Centre to promote Regulatory Excellence (CoRE) with the purpose of ensuring patients in Asia have timely access to safe, effective and high quality therapeutic products through regulatory excellence.
Targeted at the needs of the national health regulators, the biomedical industry, and pharmaceutical and medical device companies, CoRE looks to providing a platform to develop programs that builds capability among senior staff and executives, promotes regulatory leadership and encourages policy innovation across the Asia-Pacific. Ultimately, CoRE aims to create an environment in which new healthcare products can be developed, commercialised and delivered to the ASEAN patient with greater efficacy and safety.